Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitis

Puntos clave

• The aim was to create a predictive framework for assessing colectomy risk in patients with acute severe ulcerative colitis (ASUC).
• Developed a dose-exposure-response model to understand colectomy risk.
• Integrated the model into an interactive tool for personalized therapy decisions.
• Focused on utilizing infliximab as a rescue therapy for ASUC.
• The predictive framework can identify patients at high risk for colectomy.
• The interactive tool enables healthcare providers to tailor infliximab dosing.
• Individualized therapy aims to improve colectomy-free survival rates.